Consultation for study design and feasibility are provided free of charge to researchers planning cancer-related grant applications and research protocols or conducting cancer-related research (pilot and feasibility studies).

Analytical service costs are recovered through percent (%) effort of personnel, supplies and instrument time.

Pharmacokinetic, pharmacodynamic, and pharmacogenetic modeling are provided free of charge for small studies (e.g., Phase I/II).